Literature DB >> 16630297

Marginal zone B-cell lymphoma of minor salivary gland representing tumor-forming amyloidosis of the oral cavity. A case report.

Masaru Kojima1, Shiro Sugihara, Misa Iijima, Takayuki Ono, Takashi Yoshizumi, Nobuhide Masawa.   

Abstract

We report here a case of mucosa-associated lymphoid tissue (MALT)-type lymphoma arising from the minor salivary gland of the oral cavity exhibiting tumor-forming amyloidosis. The patient was a 64-year-old Japanese woman who presented with 4-year history of a left soft palate mass. Despite multiple and multifocal recurrences including the lip, soft palate, tongue, oral base and vocal code and soft palate, the tumor remained localized in the upper aerodigestive tract, and the patient did not develop multiple myeloma during the course of disease. Histologically, the majority of the lesion was occupied by amyloid deposition. Only the periphery of the lesion contained numerous plasmacytoid cells, along with occasional centrocyte-like cells. In addition, lymphoepithelial lesion and follicular colonization were noted. The present case indicates that primary minor salivary gland MALT-type lymphoma appears to be the cause of tumor-forming amyloidosis of the upper aerodigestive tract including the larynx.

Entities:  

Mesh:

Year:  2006        PMID: 16630297     DOI: 10.1111/j.1600-0714.2006.00408.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

1.  Adnexal mass secondary to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with associated amyloid deposition.

Authors:  Neha Mehta; Heiko Schöder; April Chiu; John Kenneth Schoolmeester; Carol Portlock
Journal:  BMJ Case Rep       Date:  2014-11-14

2.  [Sjögren-associated MALT-type lymphoma of labial salivary glands: rare constellation with amyloidosis and IgM-paraproteinemia].

Authors:  M J Flaig; S Ihrler
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

3.  Immunohistochemical comparison of CD5, lambda, and kappa expression in primary and recurrent buccal mucosa-associated lymphoid tissue (MALT) lymphomas.

Authors:  Toshiaki Tanaka; Kenichirou Kitabatake; Mituyoshi Iino; Kaoru Goto
Journal:  Diagn Pathol       Date:  2011-09-06       Impact factor: 2.644

4.  Histopathological variation of primary mucosa-associated lymphoid tissue lymphoma of the oral cavity.

Authors:  Masaru Kojima; Naoya Nakamura; Kazuhiko Shimizu; Masahumi Nishikawa; Morio Matsumoto; Keiko Higuchi; Nobuo Yamane; Norihumi Tsukamoto; Yoshio Tamaki; Hiroshi Inagaki
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

5.  Treatment of localized oral MALT lymphoma by rituximab: a case report.

Authors:  Kenji Yamagata; Kojiro Onizawa; Hiroshi Kojima; Hiroshi Yoshida
Journal:  Oral Maxillofac Surg       Date:  2008-10-02

Review 6.  Oral manifestations of lymphoma: a systematic review.

Authors:  Taísa Domingues Bernardes Silva; Camila Belo Tavares Ferreira; Gustavo Boehmer Leite; José Roberto de Menezes Pontes; Héliton S Antunes
Journal:  Ecancermedicalscience       Date:  2016-08-17

7.  Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass.

Authors:  Sebastiano Cicco; Antonio G Solimando; Patrizia Leone; Stefano Battaglia; Roberto Ria; Angelo Vacca; Vito Racanelli
Journal:  Case Rep Hematol       Date:  2018-10-17

8.  MALT lymphoma associated with laryngeal amyloidosis: case report.

Authors:  Leandro Castro Velasco; Laurice Barbosa Freitas; Jhessica Lima Garcia; Henrique Moura de Paula; Vitor Alves Cruz; Hugo Valter Lisboa Ramos; Claudiney Candido Costa
Journal:  Braz J Otorhinolaryngol       Date:  2021-01-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.